These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

626 related items for PubMed ID: 27421623

  • 1. Injectable Fluocinolone Acetonide Long-Acting Implant for Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Two-Year Results.
    Jaffe GJ, Lin P, Keenan RT, Ashton P, Skalak C, Stinnett SS.
    Ophthalmology; 2016 Sep; 123(9):1940-8. PubMed ID: 27421623
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of a Fluocinolone Acetonide Insert on Recurrence Rates in Noninfectious Intermediate, Posterior, or Panuveitis: Three-Year Results.
    Jaffe GJ, Pavesio CE, Study Investigators.
    Ophthalmology; 2020 Oct; 127(10):1395-1404. PubMed ID: 32624244
    [Abstract] [Full Text] [Related]

  • 5. Time to disease recurrence in noninfectious uveitis following long-acting injectable fluocinolone acetonide implant.
    Cai CX, Skalak C, Keenan RT, Grewal DS, Jaffe GJ.
    Graefes Arch Clin Exp Ophthalmol; 2020 May; 258(5):1023-1030. PubMed ID: 32114654
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial.
    Multicenter Uveitis Steroid Treatment (MUST) Trial Research GroupOcular Inflammation Service, The University of Pennsylvania, Philadelphia, Philadelphia, PA 19104, USA., Kempen JH, Altaweel MM, Holbrook JT, Jabs DA, Louis TA, Sugar EA, Thorne JE.
    Ophthalmology; 2011 Oct; 118(10):1916-26. PubMed ID: 21840602
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Combined fluocinolone acetonide intraocular delivery system insertion, phacoemulsification, and intraocular lens implantation for severe uveitis.
    Chieh JJ, Carlson AN, Jaffe GJ.
    Am J Ophthalmol; 2008 Oct; 146(4):589-594. PubMed ID: 18639220
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Reimplantation of a fluocinolone acetonide sustained drug delivery implant for chronic uveitis.
    Jaffe GJ.
    Am J Ophthalmol; 2008 Apr; 145(4):667-675. PubMed ID: 18226800
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Longitudinal Vision-Related Quality of Life for Patients with Noninfectious Uveitis Treated with Fluocinolone Acetonide Implant or Systemic Corticosteroid Therapy.
    Sugar EA, Venugopal V, Thorne JE, Frick KD, Holland GN, Wang RC, Almanzor R, Jabs DA, Holbrook JT, Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group.
    Ophthalmology; 2017 Nov; 124(11):1662-1669. PubMed ID: 28624167
    [Abstract] [Full Text] [Related]

  • 18. Effect of an Injectable Fluocinolone Acetonide Insert on Recurrence Rates in Chronic Noninfectious Uveitis Affecting the Posterior Segment: Twelve-Month Results.
    Jaffe GJ, Foster CS, Pavesio CE, Paggiarino DA, Riedel GE.
    Ophthalmology; 2019 Apr; 126(4):601-610. PubMed ID: 30367884
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.